IBDEI2L3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43861,1,4,0)
 ;;=4^N81.12
 ;;^UTILITY(U,$J,358.3,43861,2)
 ;;=^331535
 ;;^UTILITY(U,$J,358.3,43862,0)
 ;;=N60.31^^170^2107^50
 ;;^UTILITY(U,$J,358.3,43862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43862,1,3,0)
 ;;=3^Fibrosclerosis,Right Breast
 ;;^UTILITY(U,$J,358.3,43862,1,4,0)
 ;;=4^N60.31
 ;;^UTILITY(U,$J,358.3,43862,2)
 ;;=^5015779
 ;;^UTILITY(U,$J,358.3,43863,0)
 ;;=N60.32^^170^2107^49
 ;;^UTILITY(U,$J,358.3,43863,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43863,1,3,0)
 ;;=3^Fibrosclerosis,Left Breast
 ;;^UTILITY(U,$J,358.3,43863,1,4,0)
 ;;=4^N60.32
 ;;^UTILITY(U,$J,358.3,43863,2)
 ;;=^5015780
 ;;^UTILITY(U,$J,358.3,43864,0)
 ;;=N81.6^^170^2107^82
 ;;^UTILITY(U,$J,358.3,43864,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43864,1,3,0)
 ;;=3^Rectocele w/o Uterine Prolapse
 ;;^UTILITY(U,$J,358.3,43864,1,4,0)
 ;;=4^N81.6
 ;;^UTILITY(U,$J,358.3,43864,2)
 ;;=^259590
 ;;^UTILITY(U,$J,358.3,43865,0)
 ;;=Z90.11^^170^2107^10
 ;;^UTILITY(U,$J,358.3,43865,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43865,1,3,0)
 ;;=3^Acquired Absence,Breast,Right
 ;;^UTILITY(U,$J,358.3,43865,1,4,0)
 ;;=4^Z90.11
 ;;^UTILITY(U,$J,358.3,43865,2)
 ;;=^5063582
 ;;^UTILITY(U,$J,358.3,43866,0)
 ;;=Z90.12^^170^2107^9
 ;;^UTILITY(U,$J,358.3,43866,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43866,1,3,0)
 ;;=3^Acquired Absence,Breast,Left
 ;;^UTILITY(U,$J,358.3,43866,1,4,0)
 ;;=4^Z90.12
 ;;^UTILITY(U,$J,358.3,43866,2)
 ;;=^5063583
 ;;^UTILITY(U,$J,358.3,43867,0)
 ;;=Z90.13^^170^2107^8
 ;;^UTILITY(U,$J,358.3,43867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43867,1,3,0)
 ;;=3^Acquired Absence,Breast,Bilateral
 ;;^UTILITY(U,$J,358.3,43867,1,4,0)
 ;;=4^Z90.13
 ;;^UTILITY(U,$J,358.3,43867,2)
 ;;=^5063584
 ;;^UTILITY(U,$J,358.3,43868,0)
 ;;=Z98.82^^170^2107^17
 ;;^UTILITY(U,$J,358.3,43868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43868,1,3,0)
 ;;=3^Breast Implant Status
 ;;^UTILITY(U,$J,358.3,43868,1,4,0)
 ;;=4^Z98.82
 ;;^UTILITY(U,$J,358.3,43868,2)
 ;;=^5063747
 ;;^UTILITY(U,$J,358.3,43869,0)
 ;;=Z12.39^^170^2107^83
 ;;^UTILITY(U,$J,358.3,43869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43869,1,3,0)
 ;;=3^Screen,Breast CA
 ;;^UTILITY(U,$J,358.3,43869,1,4,0)
 ;;=4^Z12.39
 ;;^UTILITY(U,$J,358.3,43869,2)
 ;;=^5062686
 ;;^UTILITY(U,$J,358.3,43870,0)
 ;;=Z80.3^^170^2107^44
 ;;^UTILITY(U,$J,358.3,43870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43870,1,3,0)
 ;;=3^Family Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,43870,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,43870,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,43871,0)
 ;;=Z80.49^^170^2107^45
 ;;^UTILITY(U,$J,358.3,43871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43871,1,3,0)
 ;;=3^Family Hx of Genital Organ CA
 ;;^UTILITY(U,$J,358.3,43871,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,43871,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,43872,0)
 ;;=Z80.41^^170^2107^46
 ;;^UTILITY(U,$J,358.3,43872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43872,1,3,0)
 ;;=3^Family Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,43872,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,43872,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,43873,0)
 ;;=N89.8^^170^2107^68
 ;;^UTILITY(U,$J,358.3,43873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43873,1,3,0)
 ;;=3^Noninflammatory Disorder of Vagina,Other Specified
 ;;^UTILITY(U,$J,358.3,43873,1,4,0)
 ;;=4^N89.8
 ;;^UTILITY(U,$J,358.3,43873,2)
 ;;=^88111
 ;;^UTILITY(U,$J,358.3,43874,0)
 ;;=N76.2^^170^2107^99
 ;;^UTILITY(U,$J,358.3,43874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43874,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,43874,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,43874,2)
 ;;=^5015828
